Early postmenopausal estrogen replacement therapy may protect some women from developing Alzheimer's disease. Read More
Obesity and higher body mass are linked to decreased cerebral blood flow. Lower cerebral blood flow is associated with an increased risk of Alzheimer's disease and a range of psychiatric disorders. Read More
Study reports success in treating cognitive decline and memory loss associated with Alzheimer's disease with the aid of personalized precision medicine. Read More
Caffeine and urate have been associated with a reduced risk of idiopathic Parkinson's disease. Researchers noted a lower caffeine intake in idiopathic Parkinson's patients. Increasing caffeine consumption was linked to decreased odds of being diagnosed with Parkinson's. Lower levels of blood urate were also associated with an increased risk of Parkinson's disease. Read More
People with a genetic predisposition to Alzheimer's disease can benefit significantly from a six-month aerobic training program. Aerobic exercise helps improve brain glucose metabolism and executive function, in addition to increasing cardiorespiratory fitness. Read More
Low-intensity exercise triggers brain networks associated with cognitive control and attention processing, while high-intensity exercise activates networks involved in emotional processing. Read More
Researchers found a close association between high aluminum content in brain tissue and amyloid-beta location in post-mortem samples of people with familial Alzheimer's disease. The findings back up previous claims that aluminum exposure may be linked to the development of the neurodegenerative disease. Read More
Study reflects on the possible use of fecal microbiome transplants and pre/probiotics to help with the treatment of Parkinson's disease. Findings reveal fecal transplants have not yet been proven to be effective for motor symptoms associated with the condition, and probiotics have only been shown to assist with constipation. Read More
Scientists are conducting experiments to see if targeting the enteric nervous system with a compound can inhibit the aggregation of alpha-synuclein and slow the progression of Parkinson's disease. Read More
Study provides new insights into how the immune system and inflammation play a role in the development and progression of Parkinson's disease. Read More
Researchers propose future gut microbiome studies related to Parkinson's disease should address questions relevant to patient care. Read More
Lewy body disorders, including Parkinson's disease and Lewy body dementia, comprise of two distinct subtypes. One subtype originates in the peripheral nervous system (PNS) of the gut and spreads to the brain. The other originates in the brain, or enters the brain via the olfactory system, before spreading to the brainstem and PNS. Read More
